Avidity Biosciences
RNA
$26.86
Share price
-0.74%
Change (1 day)
147.10%
Change (1 year)
Categories
Market capitalization of Avidity Biosciences (RNA)
Market cap: $2.56 Billion
As of June 2024 Avidity Biosciences has a market cap of $2.56 Billion. This makes Avidity Biosciences the world's 3727th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Avidity Biosciences from 2020 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $2.56 B | 258.5% |
| 2023 | $0.71 B | -51.41% |
| 2022 | $1.47 B | 32.3% |
| 2021 | $1.11 B | 16.4% |
| 2020 | $0.95 B |
End of Day market cap according to different sources
On Jun 1st, 2024 the market cap of Avidity Biosciences was reported to be:
$2.56 Billion
$2.56 Billion
$2.56 Billion
$2.56 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $162.40 B | 6,222.18% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $93.92 B | 3,556.31% | 🇬🇧 UK |
 Sarepta Therapeutics
SRPT | $12.27 B | 377.84% | 🇺🇸 USA |
 PTC Therapeutics
PTCT | $2.78 B | 8.56% | 🇺🇸 USA |
 Fate Therapeutics
FATE | $0.41 B | -83.69% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $0.82 M | -99.97% | 🇺🇸 USA |
 Acceleron Pharma XLRN | $10.93 B | 325.55% | 🇺🇸 USA |
 Catalyst Pharmaceuticals CPRX | $1.90 B | -25.65% | 🇺🇸 USA |